Wolfram Pönisch

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases

Dietger Niederwieser, Michael B. Maris, Judith A. Shizuru et al. · Blood · 2003 · 455 citations · Full text

Medicine, Hematology, Immunology +17

Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO)

Wolfram Pönisch, Paris S. Mitrou, K Merkle et al. · Journal of Cancer Research and Clinical Oncology · 2006 · 192 citations · Full text

Medicine, Hematology, Oncology +13

Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem‐cell transplantation or conventional chemotherapy: results of a Phase I clinical trial

Wolfram Pönisch, Marta Rozanski, Hartmut Goldschmidt et al. · British Journal of Haematology · 2008 · 82 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Early related or unrelated haematopoietic cell transplantation results in higher overall survival and leukaemia-free survival compared with conventional chemotherapy in high-risk acute myeloid leukaemia patients in first complete remission

Nadežda Basara, Antina Schulze, Ulrich Wedding et al. · Leukemia · 2009 · 79 citations

Medicine, Hematology, Oncology +13

Digital droplet PCR-based absolute quantification of pre-transplant NPM1 mutation burden predicts relapse in acute myeloid leukemia patients

Marius Bill, Juliane Grimm, Madlen Jentzsch et al. · Annals of Hematology · 2018 · 74 citations

Medicine, Hematology, Oncology +14